As at Sep 28, 2023, the UTHR stock has a PE ratio of 12.0. This is based on the current EPS of $18.83 and the stock price of $226.03 per share. A decrease of 15% has been seen in the P/E ratio compared to the average of 14.2 of the last 4 quarters.
The mean historical PE ratio of UNITED THERAPEUTICS over the last ten years is 15.42. The current 12.0 PE ratio is 22% below the historical average. Over the past ten years, UTHR's PE ratio was at its highest in the Jun 2015 quarter at 47.14, with a price of $173.95 and an EPS of $3.69. The Jun 2016 quarter recorded the bottom point at 4.74, with a price of $105.92 and an EPS of $22.35.
Maximum annual increase: 254.1% in 2013
Maximum annual decrease: -48.36% in 2018
| Year | PE ratio | Change |
|---|---|---|
| 2022 | 17.4 | -14.62% |
| 2021 | 20.38 | 56.41% |
| 2020 | 13.03 | N/A |
| 2019 | N/A | N/A |
| 2018 | 8.04 | -48.36% |
| 2017 | 15.57 | 76.93% |
| 2016 | 8.8 | -20.36% |
| 2015 | 11.05 | -39.75% |
| 2014 | 18.34 | -43.4% |
| 2013 | 32.4 | 254.1% |
Currently, UTHR's PE ratio is below the 3, 5 and 10-year averages.
UTHR's PE ratio is lower than its peer stocks LLY and GILD, but it is greater than PFE's. UNITED THERAPEUTICS is presently trading at a lower PE ratio (12.0) than its peer group average of 47.23.
| Stock name | PE ratio | Market cap |
|---|---|---|
| PFE Pfizer Inc | 8.69 | $186.88B |
| UTHR UNITED THERAPEUTICS Corp | 11.98 | $10.59B |
| GILD Gilead Sciences Inc | 17.03 | $93.15B |
| LLY ELI LILLY & Co | 74.22 | $508.01B |
| CAH Cardinal Health Inc | 86.8 | $21.76B |
| TEVA Teva Pharmaceutical Industries Ltd | N/A | $11.5B |
| BAX Baxter International Inc | N/A | $19.04B |
| CYTK Cytokinetics Inc | N/A | $2.89B |
As of Sep 28, 2023, UTHR stock has a price to earnings ratio of 12.
The 3-year average PE ratio for UTHR stock is 15.11.
The 5-year average PE ratio for UTHR stock is 13.74.
Over the last ten years, the quarterly PE ratio reached a historic high of 47.14 in the Jun 2015 quarter.
UTHR's current price to earnings ratio is 22% below its 10-year historical average.
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Sep 28, 2023), UNITED THERAPEUTICS's stock price is $226.03. The earnings per share for the trailing twelve months (TTM) ending Jun 2023 is $18.83. Therefore, UNITED THERAPEUTICS's P/E ratio for today is 12. PE RATIO(12) = STOCK PRICE($226.03) / TTM EPS($18.83)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.